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Someone every hour of every day across the globe succumbs 
to SADS (sudden arrhythmia death syndrome).
SCD: sudden cardiac death
 Sudden cardiac death (SCD) is a leading cause of mortality worldwide 
with an estimated 15% to 20% of all deaths. SCD mostly occurs in older 
adults with acquired structural heart disease
 One of SCD type is SUNDS ( sudden unexplained nocturnal death 
syndrome (SUNDS))
 SUNDS occurs predominantly in Southeast Asia and has different terms 
but similar definitions in different countries
The numerous denominations of the
Sudden unexplained death syndrome 
 1.Lai-Tai (in Thailand and Laos): meaning "death 
during sleep". Sudden unexplained death syndrome 
(SUDS) was noted in 1977 among southeast Asian Hmong 
refugees in the United States and Canada. Between 1981 
and 1988, the Centers for Disease Control and Prevention 
reported a very high incidence of sudden death among 
young male Southeast Asians who died unexpectedly 
during sleep. 
 The victims (all males) were aged 21-54 (median 34). All 
the victims were apparently healthy before going to bed. 
http://pepsic.bvsalud.org/scielo.php?script=sci_arttext&pid=S0104-12822020000300018
The numerous denominations of the
Sudden unexplained death syndrome
2. Bangungot is the Tagalog word for "nightmare". Also 
known in Ilocano (a Philippine ethnolinguistic group) as 
batibat, it appears in the shape of an overweight man 
(bangungot) or overweight Botero-like woman (batibat) 
who sits on the chest or head of the victim (always male) 
and suffocates him to death. It is useless to try to push away 
the bangungot or batibat.
3. The Japanese call it pok-kuri. “Pokkuri” means suddenly and 
unexpectedly in Japanese. According to folklore, these 
mysterious deaths are caused by a malicious visiting spirit 
that kills men in their sleep.
Despite these multiple terms, the characteristics of these victims are 
common: 
 sudden death of young healthy individuals 
 the vast majority are males
 during nocturnal sleep 
 postmortem routine autopsy cannot explain their deaths!
The history of Brugada syndrome
 In 1986 a Polish engineer named Andrea 
Wockeczek barged into by Pedro Brugada office, 
carrying his 3-year-old son. 
 The boy, Lech, had been experiencing frequent 
fainting attacks. On several occasions, 
Wockeczek had performed chest compressions 
and mouth-to-mouth breathing to resuscitate him 
 Wockeczek was tragically familiar with these 
attacks. His 2-year-old daughter, Eva, had died 
several months before under similar 
circumstances. Doctors at his local hospital in 
Poland were unable to explain why she had died, 
and they were similarly stumped by Lech’s 
symptoms.
 Desperate to save his son, Wockeczek snuck him 
out of the country.
The history of Brugada syndrome
 Brugada’s first impression was that Lech was perfectly healthy. He 
was large for his age, with deep-blue eyes and curly blond locks. His 
heartbeat sounded normal, too, but when Brugada examined his 
ECG, he saw a pattern that he had never seen before
 Lech was admitted to the coronary care unit at the Maastricht 
University. For the first two days, he was fine. On the third day, 
however, he developed a sore throat and
a mild fever. 
 That night, telemetry alarms 
sounded. When a nurse got to his bedside, 
Lech was unconscious, and a monitor 
showed his heart was fibrillating. 
The nurse started CPR, and an external 
defibrillator shock was applied, restarting the
tiny heart.
The history of Brugada syndrome
 After the arrhythmia, all manner of tests were 
performed. A catheter snaked into the boy’s heart 
revealed no coronary anomalies. X-rays and an 
echocardiogram were normal. 
Even tiny biopsies taken of his heart were negative.
 Lech stayed in the hospital for several weeks. 
He had more episodes of cardiac arrest that were
treated with cocktails of anti-arrhythmic drugs. In the 
end,  a pacemaker was used to maintain a constant 
minimum  heartbeat, because doctors observed that 
his arrhythmias often started during sleep, when his heartbeat 
slowed. (Implantable defibrillators were not yet widely available.)
 Despite the prolonged investigation, the cause of the ventricular fibrillation 
remained undiagnosed. Father and son returned to Poland with a follow-up 
appointment with Brugada. When they returned to see Brugada, Wockeczek
brought the EKG of his deceased daughter, Eva. It was identical to Lech’s.
The history of Brugada syndrome
 Over the next few years, Brugada searched for this 
electrical  pattern in other victims of cardiac arrest. 
 “I looked everywhere for  this ECG but I found 
nothing,” he told. 
He collected a few more of these unusual EKGs and 
continue this work with his brother,  Josep. 
It was soon dubbed Brugada syndrome, and it and 
SUDS, from Southeast Asia, were essentially shown by 
cardiologists and epidemiologists to be the same 
disease.
 Sad conclusion: Once patients develop symptoms —
unexplained fainting is most common — there is a 50-
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Brugada syndrome: definition and epidemiology
 The Brugada syndrome (BrS) is a hereditary arrhythmia syndrome manifesting as 
recurrent syncope or sudden cardiac death (SCD) due to polymorphic 
ventricular tachucardia (VT) or fibrillation (VF) in the absence of overt structural 
heart disease or myocardial ischemia.
 The prevalence of the syndrome is estimated at around 15 per 10,000 in South 
East Asia including Japan and around 2 per 10,000 in the Western countries.
 The BrS may be responsible for up to 4 % of all sudden cardiac deaths (SCD) 
and at least 20 % of SCDs in patients with structurally normal hearts. It is 8–10 
times more prevalent in males than in females and males are at considerably 
higher risk of dying suddenly.
 The severity of symptoms varies from person to person. There are some known 
triggers for Brugada syndrome like fever and sodium blocking drugs.
MILESTONES IN OUR UNDERSTANDING OF 
BRUGADA SYNDROME
 It has been 100 years since the first description of SUNDS in 1917 in the Philippines.
 As a disorder mainly prevalent in Southeast Asia, SUNDS did not attract worldwide 
attention until 1981, when its first report was submitted to the Centers for Disease Control 
and Prevention. 
 A report is detailing sudden, unexpected deaths during sleep among mostly young, male, 
Southeast Asian refugees in the United States. Thirty-three of those who died were from 
Laos, four were from Vietnam, and one was from Cambodia. 
 1991 – Brugada and Brugada presented an abstract in the NASPE meeting of a new 
clinical-cardiologic syndrome, characterized by the association of RBBB, persistent ST 
segment elevation, normal QT interval, and SCD
 2002 – Genetic studies showed that unexplained nocturnal SCD syndrome, known as 
sudden unexplained nocturnal death syndrome, and Brugada disease are phenotypically, 
genetically, and functionally identical and allelic since both affect the same gene: SCN5A.
Causes of Brugada syndrome 
 The primary gene known to be associated with Brugada
syndrome is located on chromosome 3 and has been
termed the SCN5A gene. Approximately 15%-30% of
individuals with Brugada syndrome have a SCN5A gene 
mutation. This gene is responsible for the production of a 
protein that allows movement of sodium atoms into heart 
muscle cells through a channel called the sodium channel. 
 Abnormalities in the SCN5A gene change the structure 
or function of the sodium channel and result in a reduction of 
sodium into the heart cells. Reduced sodium can lead to an
abnormal heart  rhythm that can  lead to sudden death. 
 The SCN5A gene mutations are also associated with the
long QT  syndrome type 3 (LQT3), which is one form of a heart 
rhythm abnormality called Romano-Ward syndrome. 
Some families have been reported that have relatives with 
Brugada syndrome and LQT3, suggesting that these conditions 
may be different types of the same disorder.
 Currently, more than 250 mutations associated with BrS
have been reported in 18 different genes Despite the
identification of 18 associated genes, 65%–70% of 




Diagnosis: the ECG is a key to the diagnosis of 
the brugada syndrome
 Type 1 Brugada ECG pattern (so-called “coved” ) 
– is the diagnostic hallmark of BrS. It characterized by J-point
elevation with slowly descending or concave ST segment 
elevation merging into a negative or reaching the isoelectric 
line symmetric T wave. 
The type 1 Brugada ECG pattern is observed most frequently 
in leads V1 and V2, much less frequently in lead V3.
Diagnosis: the ECG is a key to the diagnosis of 
the Brugada syndrome
 Type 2 and 3
Type 2 and 3 are defined as the “saddle-back pattern,”
which is defined as an incomplete right bundle branch
block (IRBBB) with ST-segment elevation 
(type 2 with ≥0.1 mV and type 3 
 Although type 1 is the hallmark of patients with BrS,
types 2 and 3 patterns should be distinguished from
incomplete RBBB, present in 3% of the population
 To diagnose Brugada types 2 or 3, patients undergo 
antiarrhythmic drug challenge (AAD) to unmasked 
the Na/K channel dysfunction and convert to type 1. 
 If the patient does not convert to type 1, then it is presumed 
an IRBBB and not Brudaga pattern.
ECG types of Brugada syndrome
Incomplete Right bundle branch block
For establishing diagnosis BrS
patient must have 1of:
 Documented ventricular fibrillation (VF) or polymorphic ventricular 
tachycardia (VT).
 Family history of sudden cardiac death at <45 years old .
 Coved-type ECGs in family members.
 Inducibility of VT with programmed electrical stimulation .
 Syncope.
 Nocturnal atonal respiration (abnormal pattern of breathing and 
brainstem reflex characterized by gasping, labored breathing, 
accompanied by strange vocalizations and myoclonus).
 Genetics is not currently used to make a diagnosis, but it can be used for 
family screening, in the case of a clinical diagnosis of Brugada and the 
finding of the genetic mutation in the proband.
TREATMENT
 No specific cure for Brugada syndrome exists, so far.
Recommendations for treatment of asymptomatic 
individuals are controversial. 
 Individuals at a high risk of ventricular fibrillation are 
treated with an implantable cardioverter defibrillator (ICD).
This device detects the abnormal heartbeat automatically
and selectively delivers an electrical impulse to the heart restoring 
normally rhythm.
 Drug therapy in BrS has several utilities: first, in the acute management of 
arrhythmic storm; second, in prevention of arrhythmic events in patients with 
implanted ICD who require many shocks; and third, as an alternative to ICD 
implantation when the latter is contraindicated, not feasible (infants and young 
children), unaffordable, or refused by the patient.
 Other treatment is symptomatic and supportive.
Implantable Cardioverter Defibrillator 
(ICD)-an ICD, is a device implanted in the 




ECG of patient with BrS
The beginning of VF in patient with BrS
How does ICD work
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Support groups for 
patients with BrS
Key messages about Brugada 
syndrome
 Brugada syndrome is now believed to be responsible for as 
many as 20 percent of deaths in patients with structurally normal 
hearts.
 Typical ECG patterns are the key in BrS diagnosis
 For now, the only effective treatment remains an implantable 
defibrillator.
 Since its introduction as a clinical entity in 1992, the Brugada 
syndrome has progressed from being a rare disease to one that 
is second only to automobile accidents as a cause of death 
among young adults in some countries.
Sudden and unexplained death in sleep (SUDS) is a leading
cause of death of young men in several Asian populations.
The photo shows Hmong men 
in Huay Nam Khao refugee 
camp, praying for a peaceful 
life. 
From the Bangkok Post.
Thank you for your attention!
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